Adapting pharmacological dose-finding designs for early phase behavioral intervention development research
Elizabeth Kuhl Towner1, April Idalski Carcone1, Samiran Ghosh1
1Department of Family Medicine and Public Health Sciences.
Abstract:
The use of systematic dose-finding designs to develop behavioral health interventions is lacking. In contrast, drug development research consistently follows a prescribed, regulated, and iterative pathway that begins with empirically establishing optimal drug dose. Adapting dose-finding methodologies from the drug development literature offers several advantages to increasing the feasibility, efficiency, and rigor of this important intervention refining step for behavioral intervention development. This article discusses the current state of the science for dose finding within the behavioral intervention development literature. A detailed overview of one drug development dose-finding methodology (the Accelerated Biased Coin Up-and-Down design) is then presented, using our work to adapt the Prevention Plus Intervention for treatment of pediatric obesity for mHealth delivery as an example of how this design can be applied to empirically derive the dose for a behavioral intervention. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
More Related Videos
Related Concept Videos
Dosage Regimens: Designs and Approaches
Dosage Regimens: Partial Pharmacokinetic Parameters
Preclinical Development: Overview
Dosage Regimen: Individualization
Measurement of Bioavailability: Pharmacodynamic Methods
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs


